Today: 19 May 2026
Qualcomm stock price jolts after-hours as QCOM flags memory crunch in outlook
5 February 2026
2 mins read

Qualcomm stock price jolts after-hours as QCOM flags memory crunch in outlook

New York, Feb 4, 2026, 19:03 EST — After-hours

Qualcomm Incorporated’s shares swung sharply in after-hours trading Wednesday after the chipmaker flagged that its “near-term handsets outlook is impacted by industry-wide memory supply constraints” and offered a softer view for the current quarter. The stock hit $134 before settling at $148.89. Qualcomm reported a record quarterly revenue of $12.252 billion and non-GAAP earnings per share (EPS) of $3.50. For fiscal second quarter, the company guided revenue between $10.2 billion and $11.0 billion, with non-GAAP EPS ranging from $2.45 to $2.65. The non-GAAP figures exclude items like stock-based compensation. Qualcomm also confirmed it completed the acquisition of Alphawave Semi. SEC

Qualcomm CEO Cristiano Amon told Reuters the forecast miss was solely due to a memory-chip shortage impacting smartphone clients. “I’m very happy with the business — I just wish we had more memory,” he said, as Chinese phone makers (OEMs) cut back inventories. Bob O’Donnell, chief analyst at TECHnalysis Research, warned the “worldwide memory crunch” could linger for “the next several quarters.” Counterpoint Research projects a 7% drop in advanced smartphone chip shipments in 2026 amid rising memory prices. Qualcomm is pushing beyond phones into PCs, automotive, and data centers, reacting to Apple and Samsung developing more in-house chips and MediaTek ramping up Android competition. Amon added the memory shortage won’t slow the release of Qualcomm’s AI data-center chips, slated for H2 this year, with meaningful revenue expected in fiscal 2027. Qualcomm shares have fallen over 11% so far in 2026. Reuters

This matters now because memory remains a tight bottleneck. When storage chips grow scarce and more expensive, handset makers can’t simply “work around it” through software fixes; they either cut shipments or alter their product mix, directly impacting chip orders.

Qualcomm’s position near the premium smartphone supply chain means inventory shifts hit it fast. When OEMs cut back on production, chipmakers are the first to notice. Then the debate kicks off—demand, supply, or a mix of both?

The memory shortage complicates things for investors, muddying the true picture of demand. Consumers might still crave flagship phones, yet limited component supplies force lower launch volumes and push upgrade cycles further out.

Qualcomm’s expansion into cars and data centers aims to steady that volatility. It provides some relief, but the short-term reality remains: handset volumes and mix still dictate the quarter-to-quarter swings.

The downside is straightforward: if memory bottlenecks and pricing pressures persist, OEMs might slash production once more, making Qualcomm’s forecasts look overly optimistic. While the premium segment holds up better than mid-range, it still feels the pinch when costs climb.

Another, more persistent risk is tougher to quantify: customers gradually bringing silicon design in-house or switching suppliers piece by piece. These changes usually don’t happen all at once—until suddenly, they do.

Traders will be eyeing Thursday’s regular session to see if the after-hours action holds and how the stock performs when liquidity comes back. The bigger issue: is the handset slowdown just a one-quarter pause, or the beginning of a more prolonged reset?

Investors are pushing for clearer signals on when customers will halt inventory drawdowns and resume ordering. They also want to see if the data-center roadmap shifts from being mere talk to actual booked revenue.

The next key event on the calendar is the premium smartphone launch cycle at Mobile World Congress in Barcelona, scheduled for March 2-5. This will offer a clear glimpse of upcoming trends in high-end Android devices and component supply.

Stock Market Today

  • When Will Island Pharmaceuticals Limited (ASX:ILA) Reach Profitability?
    May 19, 2026, 3:26 AM EDT. Island Pharmaceuticals Limited (ASX:ILA), a drug repurposing company focusing on antiviral therapeutics in Australia and the U.S., posted a AU$3.9 million loss in the latest financial year and a AU$7.2 million loss over the trailing twelve months. Analysts project the company will break even in 2027 and reach a profit of AU$295 million by 2028. This forecast implies an ambitious average annual growth rate of 140%. Notably, Island Pharmaceuticals operates with no debt, relying solely on shareholder funding, which reduces financial risk typical in cash-burning pharmaceutical firms. Investors anticipate milestone developments but should remain cautious of the high growth assumptions given the volatile nature of pharmaceutical cash flows during drug development phases.

Latest articles

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

19 May 2026
Dominion Energy shares jumped 9.4% after agreeing to an all-stock merger with NextEra Energy, whose shares fell 4.6%. The S&P 500 slipped 0.1% and the Nasdaq dropped 0.5% as investors sold technology stocks amid rising Treasury yields and oil prices. Nvidia fell 1.4% ahead of earnings. U.S. crude settled at $107.37, and the 10-year Treasury yield reached 4.59%.
XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

19 May 2026
XP Inc.’s U.S.-listed shares fell 3.78% in after-hours trading Monday after reporting higher Q1 profit but weaker net inflows and a lower retail take rate. Net income rose 7% to 1.32 billion reais, but net inflow dropped to 14 billion reais from 24 billion a year earlier. The company declared a $0.20 dividend and announced a new CFO, Gustavo Alejo Viviani, starting August 3.
LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

19 May 2026
Publicis Groupe agreed to buy LiveRamp Holdings for $38.50 a share in cash, valuing the U.S. data-collaboration firm at $2.546 billion. LiveRamp stock jumped to $37.77 on the news, while the broader market fell. LiveRamp reported fiscal Q4 revenue of $206 million, up 9% from a year earlier. Publicis said the deal will boost its adjusted earnings per share from the first year after closing.

Popular

Zeta Global Surges 12% After OpenAI Ad Remarks

Zeta Global Surges 12% After OpenAI Ad Remarks

19 May 2026
Zeta Global shares rose 11.6% to $19.19 Monday after CEO David Steinberg said the company reached an agreement to help OpenAI run its advertising. The stock outperformed the broader market, with SPY and QQQ both down. Zeta recently joined Snowflake’s Open Semantic Interchange and reported Q1 revenue up 50% year-over-year. Investors cited strong guidance and increased Athena AI agent usage.
Coinbase stock slides after Nevada lawsuit over sports event contracts; earnings ahead
Previous Story

Coinbase stock slides after Nevada lawsuit over sports event contracts; earnings ahead

KKR stock jumps after-hours as $5.2 billion data-center deal lands before earnings
Next Story

KKR stock jumps after-hours as $5.2 billion data-center deal lands before earnings

Go toTop